Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
55.82
-16.64 (-22.96%)
At close: May 9, 2025, 4:00 PM
55.80
-0.02 (-0.04%)
After-hours: May 9, 2025, 7:58 PM EDT
Globus Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 2,511 | 2,519 | 1,568 | 1,023 | 958.1 | 789.04 | Upgrade
|
| Revenue Growth (YoY) | 32.26% | 60.62% | 53.34% | 6.76% | 21.43% | 0.47% | Upgrade
|
| Cost of Revenue | 827.41 | 819.88 | 476.52 | 262.83 | 239.22 | 217.46 | Upgrade
|
| Gross Profit | 1,683 | 1,699 | 1,092 | 760.01 | 718.88 | 571.58 | Upgrade
|
| Selling, General & Admin | 971.6 | 977.48 | 643.41 | 432.12 | 408.15 | 354.76 | Upgrade
|
| Research & Development | 137.39 | 161.6 | 124.01 | 73.02 | 97.35 | 84.52 | Upgrade
|
| Operating Expenses | 1,227 | 1,258 | 818.45 | 522.87 | 524.02 | 456.11 | Upgrade
|
| Operating Income | 455.91 | 441.03 | 273.51 | 237.15 | 194.86 | 115.47 | Upgrade
|
| Interest Expense | -2.3 | -4.19 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 1.68 | - | 20.13 | 14.23 | 9.3 | 13.95 | Upgrade
|
| Currency Exchange Gain (Loss) | -23.64 | -43.29 | 14.26 | -1.02 | -1.42 | -0.28 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.13 | 1.57 | -1.35 | 7.24 | 3.36 | 1.38 | Upgrade
|
| EBT Excluding Unusual Items | 432.78 | 395.12 | 306.55 | 257.6 | 206.09 | 130.53 | Upgrade
|
| Merger & Restructuring Charges | -200.6 | -274.72 | -139.93 | -6.85 | -16.98 | -4.03 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.08 | 0.64 | -0.79 | -5.39 | -2.78 | -0.59 | Upgrade
|
| Legal Settlements | -0.31 | -0.31 | -0.43 | -2.34 | -5.92 | -0.01 | Upgrade
|
| Pretax Income | 232.95 | 120.72 | 165.39 | 243.02 | 180.41 | 125.9 | Upgrade
|
| Income Tax Expense | 47.39 | 17.74 | 42.52 | 52.85 | 31.22 | 23.61 | Upgrade
|
| Net Income | 185.56 | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 | Upgrade
|
| Net Income to Common | 185.56 | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 | Upgrade
|
| Net Income Growth | 178.51% | -16.19% | -35.39% | 27.47% | 45.86% | -34.10% | Upgrade
|
| Shares Outstanding (Basic) | 136 | 136 | 113 | 100 | 101 | 99 | Upgrade
|
| Shares Outstanding (Diluted) | 139 | 138 | 115 | 103 | 104 | 101 | Upgrade
|
| Shares Change (YoY) | 13.05% | 20.27% | 11.68% | -0.95% | 2.63% | -1.01% | Upgrade
|
| EPS (Basic) | 1.36 | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 | Upgrade
|
| EPS (Diluted) | 1.34 | 0.75 | 1.07 | 1.85 | 1.44 | 1.01 | Upgrade
|
| EPS Growth | 145.70% | -29.91% | -42.16% | 28.47% | 42.57% | -33.55% | Upgrade
|
| Free Cash Flow | 522.59 | 405.21 | 165.23 | 104.42 | 219.38 | 135.14 | Upgrade
|
| Free Cash Flow Per Share | 3.76 | 2.94 | 1.44 | 1.02 | 2.12 | 1.34 | Upgrade
|
| Gross Margin | 67.05% | 67.46% | 69.62% | 74.30% | 75.03% | 72.44% | Upgrade
|
| Operating Margin | 18.16% | 17.51% | 17.44% | 23.18% | 20.34% | 14.63% | Upgrade
|
| Profit Margin | 7.39% | 4.09% | 7.83% | 18.59% | 15.57% | 12.96% | Upgrade
|
| Free Cash Flow Margin | 20.81% | 16.08% | 10.53% | 10.21% | 22.90% | 17.13% | Upgrade
|
| EBITDA | 720.75 | 695.05 | 418.24 | 305.4 | 264.73 | 178.35 | Upgrade
|
| EBITDA Margin | 28.71% | 27.59% | 26.66% | 29.86% | 27.63% | 22.60% | Upgrade
|
| D&A For EBITDA | 264.84 | 254.02 | 144.73 | 68.25 | 69.87 | 62.87 | Upgrade
|
| EBIT | 455.91 | 441.03 | 273.51 | 237.15 | 194.86 | 115.47 | Upgrade
|
| EBIT Margin | 18.16% | 17.51% | 17.44% | 23.18% | 20.34% | 14.63% | Upgrade
|
| Effective Tax Rate | 20.34% | 14.69% | 25.71% | 21.75% | 17.30% | 18.76% | Upgrade
|
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.